Table 1.
Baseline Characteristics Overall and by Arma
| Full Sample (N=62) |
PFIT (n=32) |
ST (n=30) |
|
|---|---|---|---|
| Age | 13.12 (2.68) | 12.61 (2.55) | 13.66 (2.75) |
| Gender (% female) | 44% | 50% | 37% |
| Minority (%) | 29% | 28% | 30% |
| SSRI | 20% | 19% | 21% |
| CYBOCS | 25.48 (3.51) | 25.53 (3.72) | 25.43 (3.33) |
| CGI-S | 5.28 (0.80) | 5.35 (0.80) | 5.20 (0.81) |
| Comorbid diagnoses (%) | |||
| Anxiety | 45% | 47% | 43% |
| Depression | 15% | 13% | 18% |
| ADHD | 22% | 19% | 25% |
| ODD/CD | 10% | 16% | 4% |
| Chronic tic/Tourette | 12% | 13% | 11% |
| Autism spectrum | 5% | 10% | 0% |
Note. Anxiety diagnoses include separation, social, generalized, and specific phobia; depression includes major depressive disorder and dysthymia. ADHD = attention-deficit/hyperactivity disorder; CD = conduct disorder; CGI-S = Clinical Global Impression Scale – Severity; CYBOCS = Children’s Yale-Brown Obsessive Compulsive Scale; ODD = oppositional defiant disorder; PFIT = Positive Family Interaction Therapy; SSRI = selective serotonin reuptake inhibitor; ST = standard evidence-based treatment; minority, ethnic and/or racial minority status.
a
No significant group differences on any demographic or clinical variables at baseline.